Virginia naloxone maker to launch generic version, drop list price by $3,922
(By Alia Paavola for Becker’s Hospital Review) A month after Kaleo came under fire for raising the price of its opioid antidote
Read More
Part D/Prescription Drugs
Experts look at policies and possible trade-offs to reduce drug prices
The experts weigh in on what policies and possible trade-offs are there if we were to adopt certain policies to
Read MoreCVS-Aetna deal will save money by cutting supply chain negotiations
(By Kathleen Iacocca for STAT) CVS’s $69 billion acquisition of Aetna continues to lurch toward closure — the deal doesn’t
Read More‘We’re Fighting For Our Lives’: Patients Protest Sky-High Insulin Prices
(By Bram Sable-Smith, Side Effects Public Media for Kaiser Health News) Angela Lautner knew her thirst was unusual, even for
Read MoreGottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market
(By Nicholas Florko for STAT) WASHINGTON — FDA Commissioner Scott Gottlieb blasted insulin makers Tuesday for what he called unacceptably
Read MoreProbe of US generic drug ‘cartel’ grows to 16 companies, 47 states
What began as a lawsuit over the prices of two drugs has grown to become a 47-state case involving at
Read MoreA unit of Johnson & Johnson to pay $360 million to resolve charity kickback probe
The Justice Department announced that Johnson & Johnson until will pay the U.S. government $360 million to resolve an investigation
Read MoreDemocrats are suddenly eyeing a valuable pharma asset: its patents
(By Lev Facher for STAT) WASHINGTON — Forget the push to bring more generics to market or to tweak Medicare’s
Read MoreToday is the deadline for Medicare Open Enrollment
Today is the deadline to sign up for this year’s Medicare open enrollment. If you are 65 years old or
Read MoreAvoiding Medicare enrollment pitfalls
Medicare’s open enrollment deadline is December 7th. This year, patients have several new options to consider and can look forward
Read More